Accumulating data demonstrate that IL-8 is expressed by prostate cancer cells in which it contributes to increased angiogenesis, metastasis, and progression toward castration and chemotherapy resistance [31, 32]. The gene discussed is CXCL8; the disease is prostate carcinoma.